Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002011709 | SCV002298877 | uncertain significance | not provided | 2021-08-19 | criteria provided, single submitter | clinical testing | Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. This variant has not been reported in the literature in individuals affected with SEMA4A-related conditions. This variant is not present in population databases (ExAC no frequency). This sequence change replaces proline with serine at codon 595 of the SEMA4A protein (p.Pro595Ser). The proline residue is weakly conserved and there is a moderate physicochemical difference between proline and serine. |
Ambry Genetics | RCV004046668 | SCV003562822 | uncertain significance | not specified | 2021-07-09 | criteria provided, single submitter | clinical testing | The c.1783C>T (p.P595S) alteration is located in exon 15 (coding exon 14) of the SEMA4A gene. This alteration results from a C to T substitution at nucleotide position 1783, causing the proline (P) at amino acid position 595 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Genome- |
RCV003339894 | SCV004048604 | uncertain significance | Cone-rod dystrophy 10 | 2023-04-11 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV003339893 | SCV004048605 | uncertain significance | Retinitis pigmentosa 35 | 2023-04-11 | criteria provided, single submitter | clinical testing |